ETON
Eton Pharmaceuticals Inc
NASDAQ: ETON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$54.77
-1.53% today
Updated 2026-10-06
Market cap
$1.65B
P/E ratio
147.90
P/S ratio
15.61x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$14 – $66
Volume
0.6M
Eton Pharmaceuticals Inc (ETON) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$54.77
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 12.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.